The Symphony Robotics product is not cleared by the FDA and is not approved for clinical use.

About Symphony Robotics™

At Symphony Robotics™ (SR), we are pioneering the future of neurosurgery with an advanced, ultra-maneuverable surgical micro-robot designed to transform the treatment of brain tumors, particularly Glioblastoma Multiforme (GBM).

Our core innovation is a non-linear, flexible micro-robotic arm that navigates complex brain structures with unmatched precision, guided by real-time MRI imaging and powered by AI and computer vision. This breakthrough technology, developed at Case Western Reserve University with over $10 million in NIH and NSF grants, enables surgeons to perform minimally invasive procedures with enhanced control and safety. SR holds exclusive rights to apply this technology in brain surgeries, offering a revolutionary alternative to traditional craniotomies.

FAQs

  • Symphony Robotics™ is developing an advanced surgical micro-robot designed to revolutionize neurosurgery, with a focus on treating Glioblastoma Multiforme (GBM). Our technology combines a non-linear, flexible robotic arm with real-time MRI guidance, AI, and computer vision, allowing precise and minimally invasive brain surgeries.

  • Our robotic arm is ultra-maneuverable and flexible, capable of navigating complex brain structures without the need for craniotomies (large skull incisions). It integrates with MRI systems, using magnetic fields for precise control, which minimizes damage to healthy brain tissue and provides surgeons full access to tumors in a single procedure.

  • Most brain pathologies must still be accessed by drilling and removing part of the skull bone. The drilled-out hole in the skull needs to be large enough (the size of a coffee cup) to allow sufficient access. This can cause multiple issues, including local brain trauma, a significant wound, and a long healing process.

  • We are initially targeting:

    • Laser Interstitial Thermal Therapy (LITT): A growing treatment for brain cancer and epilepsy.

    • Convection Enhanced Drug Delivery (CED): A precision medicine approach for delivering targeted therapies directly to brain tissue.

  • Traditional glioblastoma (GBM) surgeries often require invasive craniotomies, posing risks like brain trauma and treatment delays. Our flexible robotic arm offers a safer, less invasive solution by allowing deep-seated tumor access without opening the skull, significantly improving patient outcomes.

  • Watch our concept video to see the technology in action, or contact us directly through the form on our website for more information, including investment and partnership opportunities.